So sorry, I didn't mean to confuse people! There are a lot of comments in that thread and I wanted to make sure people who were too busy to go through all of it could see those that appeared to be more relevant. I won't do that again.
Thanks for clarifying with a more accurate timeline.
Someone in the facebook thread says it's $500k for 6 months.
It's worth noting that while Matt has had big improvements in one month, someone else says that their own progression slowed to nothing during the Brainstorm trial but no actual improvements. Then progression returned 2 months after...
As some of you may know, Brainstorm granted one PALS free access to NurOwn as a 'thank you' for the work he did on Right to Try. He is not in a trial but is being given the course separately.
His update is on Facebook -- matt.bellinski.7
Mod note -- not linking directly due to fundraising...
So based on the results we have seen now, are you both not really optimistic that this is the important drug we have all been waiting for? Or is it still too early to really get any hard sense?
This biotech journalist seems to think that Nurown is a fail...
Can someone much smarter than me explain what the trial results are saying right now?
Is it possible for a couple people to report great improvement and the drug to still fail? This is way above my paygrade.
Thought you guys might be interested to hear how the Brainstorm conference call went today. Seems like the CEO Chaim Lebovits really wants to make NurOwn available but the logistics are up in the air and nothing is confirmed...
I have heard rumors that they might give it to a few PALS that helped push through RTT for free or at a discounted rate and pretty much everyone else will have to pay the full, sky high price. I hope this isn't the case